Glycine Transporter 1 Inhibitors and the Promise of a New Schizophrenia Therapy

被引：1
|
作者：
Abdel-Magid, Ahmed F. [1 ,2 ]
机构：
[1] Therachem Res Medilab India Pvt Ltd, Jaipur, Rajasthan, India
[2] 1383 Jasper Dr, Ambler, PA 19002 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2016年 / 7卷 / 06期
关键词：
D O I：
10.1021/acsmedchemlett.6b00183
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：549 / 551
页数：3
相关论文
共 50 条
  • [41] Glycine Reuptake Inhibitors in the Treatment of Negative Symptoms of Schizophrenia
    Thomas, Reji
    Baker, Glen
    Dursun, Serdar
    Todd, Kathryn
    Dhami, Kamaldeep
    Chue, James
    Chue, Pierre
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 24 (03): : 195 - 200
  • [42] Glycine transporter2 inhibitors: Getting the balance right
    Vandenberg, Robert J.
    Mostyn, Shannon N.
    Carland, Jane E.
    Ryan, Renae M.
    NEUROCHEMISTRY INTERNATIONAL, 2016, 98 : 89 - 93
  • [43] The first potent and selective inhibitors of the glycine transporter type 2
    Caulfield, WL
    Collie, IT
    Dickins, RS
    Epemolu, O
    McGuire, R
    Hill, DR
    McVey, G
    Morphy, JR
    Rankovic, Z
    Sundaram, H
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (17) : 2679 - 2682
  • [44] Radiosynthesis and biological evaluation of a novel non-sarcosine-based glycine transporter 1 inhibitors
    Jun, Toyohara
    Ishiwata, Kiichi
    Zhang, Jichun
    Wu, Jin
    Hashimoto, Kenji
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S251 - S251
  • [45] 1,3-Diaminopropan-2-ol Sulfonamides as potent and selective inhibitors of the glycine transporter type 1
    Rahman, Shahzad S.
    Coulton, Steven
    Herdon, Hugh J.
    Joiner, Graham F.
    Jin, Jian
    Porter, Roderick A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (06) : 1741 - 1745
  • [46] Novel Phenylene Lipids That Are Positive Allosteric Modulators of Glycine Receptors and Inhibitors of Glycine Transporter 2
    Gallagher, Casey I.
    Frangos, Zachary J.
    Sheipouri, Diba
    Shimmon, Susan
    Duman, Meryem-Nur
    Jayakumar, Srinivasan
    Cioffi, Christopher L.
    Rawling, Tristan
    Vandenberg, Robert J.
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (15): : 2634 - 2647
  • [47] Glycine transport inhibitors for the treatment of schizophrenia: Symptom and disease modification
    Javitt, Daniel C.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 468 - 478
  • [48] Individualizing antipsychotic drug therapy in schizophrenia: The promise of pharmacogenetics
    Nnadi C.U.
    Malhotra A.K.
    Current Psychiatry Reports, 2007, 9 (4) : 313 - 318
  • [49] Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain
    Dohi, Toshihiro
    Morita, Katsuya
    Kitayama, Tomoya
    Motoyama, Naoyo
    Morioka, Norimitsu
    PHARMACOLOGY & THERAPEUTICS, 2009, 123 (01) : 54 - 79
  • [50] Antinociceptive effects of glycine transporter inhibitors in neuropathic pain models in mice
    Morita, Katsuya
    Motoyama, Naoyo
    Kitayama, Tomoya
    Morioka, Norimitsu
    Dohi, Toshihiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 39P - 39P
12345